Abbott research business spin off steers clear of Pill Hill operations
A corporate shuffle at the global drug maker will not impact the company’s Mississauga diabetes and diagnostic tests division
Writer & Business Reporter
A corporate shuffle at the global drug maker will not impact the company’s Mississauga diabetes and diagnostic tests division
